4 results found
Nexis has several COVID-19 Quick Search strings to help clients quickly find meaningful insights.
Today, pharmaceutical companies face tougher expectations than ever, both from their shareholders and from consumers. Recent FCPA settlements suggest the pharma industry still has a number of unresolved risk issues to solve. Take a closer look on our blog.
Recent reports show rising due diligence failures within COVID19 related government procurement. Demand for PPE and other pandemic-related resources emphasises the need for due diligence in public procurement.
AI and ML technologies have been put at the forefront of the fight against COVID-19, but the future use of these technologies depends on one main factor: data. Read more on our blog.